Cigna Group Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
Vanguard Capital Management disclosed a beneficial ownership of 19,814,433 shares, representing 7.51% of Cigna Group's common stock as of March 31, 2026.
NYSE
The Vanguard Group reports zero beneficial ownership in Cigna Group common stock following an internal realignment that disaggregated reporting responsibilities.
NYSE
The Vanguard Group reported a 10.03% beneficial ownership in Cigna Group common stock, alongside an internal realignment affecting future reporting.
NYSE
SCHEDULE: FMR LLC Amends Cigna Group Stake to 4.0%
FMR LLC and Abigail P. Johnson have filed an amendment to their Schedule 13G, disclosing a 4.0% beneficial ownership stake in The Cigna Group as of September 30, 2025.
NYSE
SCHEDULE 13G/A: Vanguard Group Maintains Significant Passive Stake in Cigna Group, Files Amended 13G
The Vanguard Group has filed an amended Schedule 13G, reporting a 9.64% beneficial ownership stake in Cigna Group common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.4% Stake in Cigna Corporation
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.4% of Cigna Corporation's common stock as of March 31, 2025.